10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the Quarterly period ended  March 31, 2015

[] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

     SECURITIES EXCHANGE ACT OF 1934

Commission File No. 0-53030

WESTMOUNTAIN COMPANY

(Exact Name of Issuer as specified in its charter)

Colorado	26-1315305
(State or other jurisdiction	(IRS Employer File Number)
of incorporation)
181 W Boardwalk, Suite 202
Fort Collins, Colorado	80525
(Address of principal executive offices)	(zip code)

(970) 223-4499

 (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes [X]  No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(Section 232.405 of this chapter) during the preceding 12 months(or such shorter period that the registrant was required to submit and post such files. Yes [X]  No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “small reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer []	Accelerated filer []
Non-accelerated filer   [] (Do not check if a smaller reporting company)	Smaller reporting company  [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes []    No [X]

The number of shares outstanding of the registrant's common stock, as of the latest practicable date, May 13, 2015, was 9,517,402.

 

FORM 10-Q

WestMountain Company

TABLE OF CONTENTS

PART I  FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets (Unaudited) at March 31, 2015 and December 31, 2014	3
Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) for the three months ended March 31, 2015 and 2014	4
Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2015 and 2014	5
Notes to the Consolidated Financial Statements (Unaudited)	6
Item 2. Management's Discussion and Analysis and Plan of Operation	12
Item 3. Quantitative and Qualitative Disclosures About Market Risk	15
Item 4. Controls and Procedures	15
Item 4T. Controls and Procedures	15
PART II  OTHER INFORMATION
Item 1. Legal Proceedings	15
Item 1A. Risk Factors	15
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3. Defaults Upon Senior Securities	19
Item 4. Submission of Matters to a Vote of Security Holders	19
Item 5. Other Information	19
Item 6. Exhibits	20
Signatures	21

- 2 -

PART I  FINANCIAL INFORMATION

For purposes of this report, unless otherwise indicated or the context otherwise requires, all references herein to "WestMountain Company "we," "us," and "our," refer to WestMountain Company, a Colorado corporation, formerly known as WestMountain Asset Management, Inc., and our wholly-owned subsidiaries WestMountain Business Consulting, Inc., WestMountain Valuation Services, Inc., and WestMountain Allocation Analysis, Inc.

ITEM 1.  FINANCIAL STATEMENTS

WestMountain Company
Consolidated Balance Sheets
(Unaudited)
	March 31,			December 31,
	2015			2014
Assets
Current Assets:
Cash and cash equivalents	$	334,855		$	445,411
Investments in marketable securities		376,716			1,006,230
Accounts receivable, related parties		18,000			41,125
Accounts receivable		27,900			12,300
Income tax receivable		4,417			-
Note receivable, related parties		52,823			25,937
Prepaid expenses		4,697			9,807
Deferred tax asset		210,677			-
Total current assets		1,030,085			1,540,810
Property and equipment, net of accumulated depreciation of		5,659			6,173
$9,987 and $9,473, respectively
Investments in nonmarketable securities, at cost		31,645			31,645
Total assets	$	1,067,389		$	1,578,628
Liabilities and Shareholders'Equity
Current Liabilities:
Accounts payable and accrued liabilities	$	32,020		$	37,293
Deferred tax liability		85,085			107,958
Income tax payable		-			68,662
Total current liabilities		117,105			213,913
Total liabilities		117,105			213,913
Shareholders' Equity:
Preferred stock, $0.10 par value; 1,000,000 shares authorized,		-			-
none issued and outstanding
Common stock, $.001 par value; 50,000,000 shares authorized,
9,517,402 shares issued and outstanding		9,518			9,518
Additional paid-in capital		927,355			927,355
Accumulated earnings (deficit)		(131,117	)		8,952
Other comprehensive income, net		144,528			418,890
Total shareholders' equity		950,284			1,364,715
Total liabilities and shareholders' equity	$	1,067,389		$	1,578,628

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 3 -

WestMountain Company
Consolidated Statements of Operations and Comprehensive Income (Loss)
(Unaudited)
	Three Months Ended
	March 31,
	2015			2014
Revenue:
Advisory/consulting fees, related parties	$	53,600		$	38,000
Advisory/consulting fees		-			12,600
Total revenue		53,600			50,600
Operating expenses:
Selling, general and administrative expenses		84,381			100,264
Total operating expenses		84,381			100,264
Loss from operations		(30,781	)		(49,664	)
Other (expense) income
Interest income		1,886			-
Dividend income on non marketable securities		-			180,950
Loss on impairment of available for sale marketable securities		(193,634	)		-
Total other (expense) income		(191,748	)		180,950
Net income (loss) income before income taxes		(222,529	)		131,286
Income tax benefit		(82,460	)		(81	)
Net (loss) income	$	(140,069	)	$	131,367
Other comprehensive (loss) income
Unrealized (loss) income on investments in marketable equity securities, net of tax		(274,362	)		3,321
Comprehensive (loss) income	$	(414,431	)	$	134,688
Basic net (loss) income per share	$	(0.01	)	$	0.01
Diluted net (loss) income per share	$	(0.01	)	$	0.01
Basic weighted average common shares outstanding		9,517,402			9,517,402
Diluted weighted average common shares outstanding		9,517,402			9,601,985

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 4 -

WestMountain Company
Consolidated Statements of Cash Flows
(Unaudited)
	Three months ended
	March 31,
	2015			2014
Cash flows from operating activities:
Net income (loss)	$	(140,069	)	$	131,367
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		514			602
Deferred income tax (benefit) expense		(72,031	)		(81	)
Loss on impairment of available for sale marketable securities		193,634			-
Changes in operating assets and operating liabilities:
Prepaid expenses and other current assets		3,224			(1,675	)
Accounts receivable		(15,600	)		4,800
Accounts receivable, related parties		23,125			378,350
Accounts payable and accrued liabilities		(5,274	)		(78,983	)
Income tax receivable		(73,079	)		(8,441	)
Net cash (used in) provided by operating activities		(85,556	)		425,939
Cash flows from investing activities:
Loan to related party		(25,000	)		-
Purchases of investments		-			(52	)
Net cash used in investing activities		(25,000	)		(52	)
Net change in cash and cash equivalents		(110,556	)		425,887
Cash and cash equivalents, beginning of period		445,411			57,992
Cash and cash equivalents, end of period	$	334,855		$	483,879
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Income taxes	$	62,650		$	42,000
Interest	$	-		$	-
Non cash investing and financing activities
Unrealized loss (income) on investments in marketable equity securities, net of tax	$	274,362		$	(3,321	)

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 5 -

WestMountain Company.

Notes to Consolidated Financial Statements

(Unaudited)

(1) Nature of Organization and Summary of Significant Accounting Policies

Nature of Organization and Basis of Presentation

WestMountain Company, formerly known as WestMountain Asset Management, Inc. , ("we"," our" or the "Company"), was incorporated in the state of Colorado on October 18, 2007 and on this date approved its business plan and commenced operations. The consolidated financial statements include the financial information of WestMountain Company and its wholly owned subsidiaries, WestMountain Business Consulting, Inc., WestMountain Allocation Analytics, Inc. and WestMountain Valuation Services Inc. All significant intercompany accounts and transactions have been eliminated.

Unaudited Financial Information

The accompanying financial information as of March 31, 2015 and for the three months ended March 31, 2015 and 2014 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company's financial position at March 31, 2015 and its operating results for the three months ended March 31, 2015 and 2014 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company's annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") for the year ended December 31, 2014. The results of operations for the three months ended March 31, 2015 is not necessarily an indication of operating results to be expected for the year.

Commitments and Contingencies

Based on currently available information, the Company believes that it is remote that future costs related to known contingent liability exposures will exceed current accruals by an amount that would have a material adverse impact on our financial statements. As the Company learns new facts concerning contingencies, the Company reassesses its position both with respect to accrued liabilities and other potential exposures. In the case of all known contingencies, the Company accrues a liability when the loss is probable and the amount is reasonably estimable. The Company does not reduce these liabilities for potential insurance or third-party recoveries.

Income Tax Receivable

As of March 31, 2015, the Company had an income tax receivable of $4,417 that is related to estimated tax payments on deposit with federal and state taxing authorities.

Fair Value of Financial Instruments

Available-for-sale securities are accounted for on a specific identification basis. As of March 31, 2015 and December 31, 2014 respectively, we held available-for-sale marketable securities with an aggregate fair value of $376,716 and $1,006,230 respectively.  As of March 31, 2015, all of our available-for-sale securities were invested in publically traded equity holdings. Available-for-sale securities were classified as current based on the percentage of the equity controlled by the Company as well as our intended use of the assets. The Company recognized unrealized losses, net of tax, in accumulated other comprehensive (loss) income for the three months ended March 31, 2015 and 2014 in the amounts of ($274,362) and $3,321, respectively.

The Company's assets measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 at March 31, 2015 and December 31, 2014, were as follows:

- 6 -

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2015

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	March 31,
Description	(Level 1)	(Level 2)	(Level 3)	2015
Assets:
Available-for-sale
marketable securities	$376,716	$              -	$              -	$376,716

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2014

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	December 31,
Description	(Level 1)	(Level 2)	(Level 3)	2014
Assets:
Available-for-sale
marketable securities	$1,006,230	$                   -	$                   -	$1,006,230

(2)    Investments

Investments in Available for Sale Marketable Securities

The Company's investments in available for sale marketable securities as of March 31, 2015 and December 31, 2014 are summarized below.

- 7 -

					As of March 31, 2015
									Accumulated
					Share		Market/Cost		Unrealized
Company Name	Shares		Cost		Price		Value		Gain/(Loss)
Hangover Joe's Holding Corporation		868,463		99,750		0.0002		-		(99,750	)
Silver Verde May Mining Co., Inc.		246,294		46,488		0.2250	$	55,416		8,928
WestMountain Gold, Inc.		918,000		918		0.3500	$	321,300		320,382
Totals		2,032,757	$	147,156			$	376,716	$	229,560
					As of December 31, 2014
									Accumulated
					Share		Market/Cost		Unrealized
Company Name	Shares		Cost		Price		Value		Gain/(Loss)
Omni Bio Pharmaceutical, Inc.		1,707,107	$	193,635	$	0.3695	$	630,776	$	437,141
Hangover Joe's Holding Corporation		868,463		99,750		0.0028		2,432		(97,318	)
Silver Verde May Mining Co., Inc		246,294		46,488		0.2100		51,722		5,234
WestMountain Gold, Inc.		918,000		918		0.3500		321,300		320,382
Totals		3,739,864	$	340,791			$	1,006,230	$	665,439

During the three months ended March 31, 2015, the Company's investment in Omni Bio Pharmaceutical, Inc. was determined to have an other than temporary decline in value. The investment was fully impaired resulting in a loss on impairment of available for sale marketable securities of $193,634.

Investments in Nonmarketable Securities

During December 2012, NexCore Healthcare Capital Corp. entered into a restructuring whereby the Company received a stock dividend consisting of 1,645,000 Class B Units of NexCore Real Estate, LLC. NexCore Real Estate is a private company with no market for its stock. The stock dividend received in NexCore Real Estate was recorded at its cost basis which was $0. The investment in NexCore Healthcare is deemed to be nonmarketable because there is no active market for its stock. The investment in NexCore Healthcare is recorded at its original cost basis of $1,645.

During February 2012, the Company converted its $30,000 convertible note receivable into 200,000 common shares of SKRP 16, Inc. This investment is recorded at our cost of $30,000. SKRP is in the process of obtaining their ticker symbol. As no market exists for the shares, this investment is deemed an investment in nonmarketable securities and is accounted for under the cost method.

The Company's investments in nonmarketable securities accounted for under the cost method as of March 31, 2015 and December 31, 2014 are summarized below.

	March 31, 2015						December 31, 2014
					Market/Cost						Market/Cost
Company Name	Shares		Units		Value		Shares		Units		Value
Nonmarketable Securities:
SKRP 16, Inc.		200,000		-	$	30,000		200,000		-	$	30,000
Nexcore Real Estate LLC (Class B Units)		-		1,645,000		-				1,645,000		-
Nexcore Healthcare Capital Corp		1,645,000		-		1,645		1,645,000		-		1,645
WestMountain Distressed Debt, Inc.		80,000		-		-		80,000		-		-
Totals Shares or Units		1,925,000		1,645,000	$	31,645		1,925,000		1,645,000	$	31,645

- 8 -

In 2008 the Company invested $50,000 for 175,000,000 shares of common stock in Marine Exploration, which represented 39% of the outstanding common stock of Marine Exploration. The Company recorded this long-term investment using the equity method of accounting for investments. Any net income or net loss must be recorded against the Company's investment, not to exceed the original investment of $50,000. Marine Exploration incurred significant losses during 2008, and the investment was reduced to zero. On August 24, 2010, Marine Exploration authorized a reverse split of 1 new share for 500 old shares of their common stock. As of this date, the Company has less than 1% ownership in Marine Exploration.

(3) Stockholders Equity

Common Stock

There were 9,517,402 shares of common stock outstanding as of March 31, 2015 and December 31, 2014. 

No common shares were issued or cancelled during the three months ended March 31, 2015.

Stock options

On August 15, 2012, the Company approved the employee compensation plan and granted a total of 200,000 common stock options, to our employees. As stated in the compensation plan, these options have a four year term. Fifty percent of the options became vested and exercisable immediately, 25% on the first anniversary date of August 15, 2012, and 25% on the second anniversary date of August 15, 2013. The options have an exercise price of $0.27 per share, which was the fair value of the stock on the day of the grant. The fair value of the options was determined to be $41,038 using the Black Scholes option pricing model.

The significant assumptions in the model included a risk free rate of 0.99%, a volatility input of 99.96% and using the simplified method, the expected term used in the calculation is 2.375 years. As of March 31, 2015, the full fair value of $41,038 has been expensed.

The following table presents the activity for common stock options during the three months ended March 31, 2015:

			Weighted
			Average
	Options		Exercise Price
Outstanding - December 31, 2014		200,000	$	0.27
Granted		-		-
Forfeited/canceled		-		-
Exercised		-		-
Outstanding - March 31, 2015		200,000	$	0.27

The weighted average remaining life of these 200,000 options as of March 31, 2015 and December 31, 2014 was 0.4 and 0.6 years respectively.

The following table presents the composition of options outstanding and exercisable as of March 31, 2015 and December 31, 2014. The exercisable options have an intrinsic value of $54,000 and $56,000 as of March 31, 2015 and December 31, 2014.

- 9 -

As of March 31, 2015:
		Options Outstanding		Options Exercisable
	Range of Exercise Prices	Number	Life	Number	Price
	0.27	200,000	0.4	200,000	0.27
As of December 31, 2014:
		Options Outstanding		Options Exercisable
	Range of Exercise Prices	Number	Life	Number	Price
	0.27	200,000	0.6	200,000	0.27

(4) Related Parties

Bohemian Companies, LLC and BOCO Investments, LLC are two companies under common control.  Mr. Klemsz, our CEO, has been the Chief Investment Officer of BOCO Investments, LLC since March 2007.  Since there is common control between the two companies and a relationship with our Company President, we are considering all transactions with Bohemian Companies, LLC and BOCO Investments, LLC, related party transactions.

On January 1, 2008, we entered into a Service Agreement with Bohemian Companies, LLC to provide us with certain defined services. These services include financial, bookkeeping, accounting, legal and tax matters, as well as cash management, custody of assets, preparation of financial documents, including tax returns and checks, and coordination of professional service providers as may be necessary to carry out the matters covered by the Service Agreement.  We compensated Bohemian Companies, LLC by reimbursing this entity for the allocable portion of the direct and indirect costs of each employee of Bohemian Companies, LLC that performs services on our behalf. We received invoices monthly from Bohemian Companies, LLC. This Service Agreement was terminated by mutual agreement of the parties on March 31, 2014.  Total expenses incurred with Bohemian Companies were $-0- and $3,000 for the three months ending March 31, 2015 and 2014, respectively. As of March 31, 2015 the Company had no balance due to Bohemian Companies, LLC.

For the three months ended March 31, 2015 and 2014, the Company recorded aggregate advisory/consulting revenue of $53,600 and $50,600, respectively. Of the $53,600 recorded in 2015, $53,600 is related party revenue for services performed on behalf of Nexcore Group LP, Bohemian Asset Management, Inc. and Omni Bio Pharmaceutical, Inc.  The Company, Nexcore and Bohemian are under common principal ownership. The Company, Nexcore and Omni Bio Pharmaceutical, Inc. are under common principal ownership.

As of March 31, 2015 and December 31, 2014, the Company had $18,000 and $41,125, respectively, of accounts receivable from related parties. 

In 2014, the Board of Directors of NexCore Healthcare Capital Corp. authorized a $0.0675 per unit cash distribution to shareholders of record on December 1, 2014. In December 2014, the Company deposited a check in the amount of $111,038. In addition, the Board of Directors of NexCore Healthcare Capital Corp authorized a $0.025 per share cash dividend to shareholders of record on December 1, 2014. The Company received and deposited a check in the amount of $41,125 in January 2015. This amount is currently recorded as a dividend and related accounts receivable as of December 31, 2014.  The distribution was received in January, 2015.

On October 17, 2014, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before April 16, 2015. As of March 31, 2015, the principal and interest due on the note is $27,046. On April 18, 2015 we carried over the principal and total interest due to a new note. The new principal amount is $27,256. The new note carries an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before October 18, 2015.

- 10 -

On January 28, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before July 28, 2015. As of March 31, 2015, the principal and interest due on the note is $25,777.

On May 4, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $10,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before November 4, 2015.

As of March 31, 2015 and December 31, 2014, the following investments in marketable and nonmarketable securities were held in related parties due to common principal ownership:

	March 31, 2015						December 31, 2014
					Market/Cost						Market/Cost
Company Name	Shares		Units		Value		Shares		Units		Value
Marketable Securities:
Omni Bio Pharmaceutical, Inc.	-		-		-		1,707,107		-		630,776
Hangover Joe's Holding Corporation		868,463	-		$	-		868,463		-	$	2,432
WestMountain Gold, Inc.		918,000		-		321,300		918,000		-		321,300
Total Shares or Units		1,786,463		-	$	321,300		3,493,570		-	$	982,309
Nonmarketable Securities:
Nexcore Real Estate LLC (Class B Units)		-		1,645,000	$	-		-		1,645,000	$	-
Nexcore Healthcare Capital Corp		1,645,000		-		1,645		1,645,000		-		1,645
WestMountain Distressed Debt, Inc.		80,000		-		-		80,000		-		-
Totals Shares or Units		1,725,000		1,645,000	$	1,645		1,725,000		1,645,000	$	1,645

On May 7, 2015 Omni Bio Pharmaceutical filed a Form 8K.  This company has been unsuccessful in its fundraising and partnering/licensing efforts and does not anticipate being able to raise sufficient capital to continue operations. Consequently, the Board of Directors of Omni Bio approved an orderly wind down, including negotiations with its senior secured creditor, Bohemian Investments, LLC. This loss in value was deemed to be other than temporary and this investment was fully impaired during the three months ended March 31, 2015 resulting in a loss on impairment of available for sale marketable securities of $193,634.

 (5) Subsequent Events

On October 17, 2014, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. Repayment of the loan was due on or before April 16, 2015. On April 18, 2015 we carried over the principal and total interest due to a new note. The new principal amount is $27,256. The new note carries an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before October 18, 2015.

On May 4, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $10,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before November 4, 2015.

On May 7, 2015 Omni Bio Pharmaceutical filed a Form 8K.  This company has been unsuccessful in its fundraising and partnering/licensing efforts and does not anticipate being able to raise sufficient capital to continue operations. Consequently, the Board of Directors of Omni Bio approved an orderly wind down, including negotiations with its senior secured creditor, Bohemian Investments, LLC. As a result of this other than temporary loss in value, the Company's investment in this Company was fully impaired during the three months ended March 31, 2015 resulting in a loss of $193,634.

- 11 -

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION

The following discussion of our financial condition and results of operations should be read in conjunction with, and is qualified in its entirety by, the consolidated financial statements and notes thereto included in, Item 1 in this Quarterly Report on Form 10-Q.  This item contains forward-looking statements that involve risks and uncertainties.  Actual results may differ materially from those indicated in such forward-looking statements.

Forward-Looking Statements

This Quarterly Report on Form 10-Q and the documents incorporated herein by reference contain forward-looking statements. Such forward-looking statements are based on current expectations, estimates, and projections about our industry, management beliefs, and certain assumptions made by our management.  Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words, and similar expressions are intended to identify such forward-looking statements.  These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict; therefore, actual results may differ materially from those expressed or forecasted in any such forward-looking statements.  Unless required by law, we undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.  However, readers should carefully review the risk factors set forth herein and in other reports and documents that we file from time to time with the Securities and Exchange Commission, particularly Annual Reports on Form 10-K, Quarterly reports on Form 10-Q and any Current Reports on Form 8-K.

General

We are a fee-based marketing, media and investor relations consultant to public and private companies.

On January 1, 2008, we entered into a Service Agreement with Bohemian Companies, LLC to provide us with certain defined services. These services included financial, bookkeeping, accounting, legal and tax matters, as well as cash management, custody of assets, preparation of financial documents, including tax returns and checks, and coordination of professional service providers as may be necessary to carry out the matters covered by the Service Agreement.  We compensated Bohemian Companies, LLC by reimbursing this entity for the allocable portion of the direct and indirect costs of each employee of Bohemian Companies, LLC that performed services on our behalf. This Service Agreement was terminated by mutual agreement of the parties on March 31, 2014. 

On February 26, 2014, we amended our Articles of Incorporation to change our name to WestMountain Company. No other changes were made to our Articles of Incorporation.

Operations

As a consultant, we provide investor relations, website development, video production, and associated marketing and media services to clients. We are paid fees for our services by our clients under written consulting agreements.

Currently, we believe that we have sufficient capital to implement our business operations or to sustain them indefinitely. We have been profitable in the past, including the most recent fiscal quarter. If we can maintain our profitability, we could operate at our present level indefinitely. To date, we have never had any discussions with any possible acquisition candidate nor have we any intention of doing so.

We have not been subject to any bankruptcy, receivership or similar proceeding.

Results of Operations

The following discussion involves our results of operations for the three months ended March 31, 2015 and 2014.

For the three months ended March 31, 2015 we had advisory/consulting revenues of $53,600 compared to $50,600 for the three months ended March 31, 2014.  This represents a 6% increase, or $3,000 over the two periods reported. Of the advisory/consulting fee revenue, $53,600 and $38,000, respectively, were from related parties.

- 12 -

All of the revenues of our clients in the first quarter ended March 31, 2015 came from entities which were under common principal ownership with our majority shareholder. This percentage represents an increase of approximately 25% over the prior year's fiscal quarter. Our revenue remains subject to greater uncertainty than if we had revenue commitments from a number of clients not under common principal ownership. We could be materially impacted if the current arrangement does not continue, and we cannot replace our current clients with other clients.

Operating expenses, consisting primarily of selling, general and administrative costs were $84,381 for the three months ended March 31, 2015, compared to $100,264 for the three months ended March 31, 2014.  The cost decrease of $15,883 over the two periods is related to contract services provided to the company. We believe that our selling, general and administrative costs will increase as we grow our business activities going forward, although we cannot predict the extent of such growth.

We had net loss of $140,069 for the three months ended March 31, 2015, compared to net income of $131,367 for the three months ended March 31, 2014. The net income decreased by $271,436 between the two periods mainly due to a dividend received from a related party investment during the prior period and the impairment of the Company investment in Omni Bio Pharmaceutical, Inc. in the amount of $193,634. Total revenue decreased 6% or $3,000, operating expenses decreased 15% or $15,883, dividend income on non-marketable securities decreased $180,950 or 100%, and loss on impairment of available for sale marketable securities increase of $193,634 or 100%. Income tax benefit increased to $82,460 for the three months ended March 31, 2015 from income tax benefit of $81 for the three months ended March 31, 2014.

On January 3, 2014, NexCore Healthcare Capital Corp. declared a $0.10 per share cash dividend to holders of NexCore common stock of record on January 16, 2014. As of that date, the Company owned 1,645,000 shares of common stock and received a cash dividend of $164,500.

As of March 31, 2015, we hold nine investment positions. All the companies classified as marketable securities are publicly traded and listed on the OTC Bulletin Board. Those classified as nonmarketable are private companies or do not have an active market for their shares. The table below lists the investments and total shares owned by us as of March 31, 2015.

Company Name	Shares		Units
Marketable Securities:
Hangover Joe's Holding Corporation		868,463		-
Silver Verde May Mining Co., Inc.		246,294		-
WestMountain Gold, Inc.		918,000		-
Total Shares or Units		2,032,757		-
Nonmarketable Securities:
SKRP 16, Inc.		200,000		-
Nexcore Real Estate LLC Class B Units		-		1,645,000
Nexcore Real Estate LLC		1,645,000		-
WestMountain Distressed Debt, Inc.		80,000		-
Total Shares or Units		1,925,000		1,645,000
Total		3,957,757		1,645,000

Our eighth position involves Marine Exploration, Inc. In 2008 the Company invested $50,000 for 175,000,000 shares of common stock in Marine Exploration, which represented 39% of the outstanding common stock of Marine Exploration. The Company recorded this long-term investment using the equity method of accounting for investments. Any net income or net loss must be recorded against the Company's investment, not to exceed the original investment of $50,000. Marine Exploration incurred significant losses during 2008, and the investment was reduced to zero. On August 24, 2010, Marine Exploration authorized a reverse split of 1 new share for 500 old shares of their common stock. As of this date, the Company has less than 1% ownership in Marine Exploration.

Our ninth position is with Omni Bio Pharmaceutical, Inc. On May 7, 2015 Omni Bio Pharmaceutical filed a Form 8K.  This company has been unsuccessful in its fundraising and partnering/licensing efforts and does not anticipate being able to raise sufficient capital to continue operations. Consequently, the Board of Directors of Omni Bio approved an orderly wind down, including negotiations with its senior secured creditor, Bohemian Investments, LLC. We invested 1,707,107 shares for a cost of $193,635. As of March 31, 2015, we fully impaired this investment resulting in a loss on impairment of available for sale marketable securities of $193,635.

- 13 -

              On October 17, 2014, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before April 16, 2015. As of March 31, 2015, the principal and interest due on the note is $27,046. On April 18, 2015 we carried over the principal and total interest due to a new note. The new principal amount is $27,256. The new note carries an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before October 18, 2015.

              On January 28, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before July 28, 2015. As of March 31, 2015, the principal and interest due on the note is $25,777.

              On May 4, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $10,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before November 4, 2015.

Liquidity and Capital Resources

As of March 31, 2015, we had cash of $334,855.

Net cash used in operating activities were $85,556 for the three months ended March 31, 2015, compared to net cash provided by operating activities of $425,939 for the three months ended March 31, 2014.

As of March 31, 2015 and December 31, 2014, the Company had $18,000 and $41,125, respectively, of accounts receivable from related parties. The amount due in 2014 represents distribution income due from Nexcore Real Estate LLC. The receivable was collected in January 2015. In addition, On May 7, 2015 Omni Bio Pharmaceutical filed a Form 8K.  This company has been unsuccessful in its fundraising and partnering/licensing efforts and does not anticipate being able to raise sufficient capital to continue operations.  Consequently, the Board of Directors of Omni Bio approved an orderly wind down, including negotiations with its senior secured creditor, Bohemian Investments, LLC. We invested 1,707,107 shares for a cost of $193,635. As of March 31, 2015, we fully impaired this investment resulting in a loss on impairment of available for sale marketable securities of $193,635.

Net cash used in investing activities was $25,000 for the three months ended March 31, 2015, compared to $52 for the three months ended March 31, 2014. The Company converted its 866,000 warrants into shares, in the first quarter of 2014 in the amount of $52.

On January 28, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan was due on or before July 28, 2015. As of March 31, 2015, the principal and interest due on the note is $25,777.

Over the next twelve months we do not expect any material capital costs for our operations.

Currently, we believe that we have sufficient capital to implement our business operations or to sustain them at our present level indefinitely. To date, we have never had any discussions with any possible acquisition candidate nor have we any intention of doing so.

We operate out of one office in Colorado. We have no specific plans at this point for additional offices.   

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements with any party.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to use judgment in the application of accounting policies, including making estimates and assumptions. We base our estimates on historical experience and on various other assumptions believed to be reasonable under the circumstances. These judgments affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions had been different, it is possible that different accounting policies would have been applied resulting in a different presentation of our financial statements. From time to time, we evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current information. Below is a discussion of accounting policies that we consider critical in that they may require complex judgment in their application or require estimates about matters that are inherently uncertain.

- 14 -

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

None.

ITEM 4. CONTROLS AND PROCEDURES

Not applicable.

ITEM 4T. CONTROLS AND PROCEDURES

As of the end of the period covered by this report, based on an evaluation of our disclosure controls and procedures (as defined in Rules 13a -15(e) and 15(d)-15(e) under the Exchange Act), our Chief Executive Officer and Chief Financial Officer has concluded that our disclosure controls and procedures are not effective to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the applicable time periods specified by the SEC's rules and forms due to the existence of material weaknesses.

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 240.13a-15(e) or Rule 240.15d-15(e) of this chapter that occurred during our most recent fiscal three months that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

This report does not include an attestation report by our independent registered public accounting firm regarding internal control over financial reporting.

PART II.  OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

There are no legal proceedings, to which we are a party, which could have a material adverse effect on our business, financial condition or operating results.

ITEM 1A.  RISK FACTORS

You should carefully consider the risks and uncertainties described below; and all of the other information included in this document. Any of the following risks could materially adversely affect our business, financial condition or operating results and could negatively impact the value of your investment.

The occurrence of any of the following risks could materially and adversely affect our business, financial condition and operating result. In this case, the trading price of our common stock could decline and you might lose all or part of your investment.

Risks Related to Our Business and Industry

We have a limited operating history. We have not been profitable for our two most recent fiscal years We may never be profitable again, and, as a result, we could go out of business.

We were formed as a Colorado business entity in October, 2007. At the present time, we have not been profitable at our two most recent fiscal year ends, and we were not profitable in our most recent fiscal quarter. We cannot guarantee that we will be profitable again, and, as a result, we could go out of business.

- 15 -

Our lack of substantial operating history makes it difficult for us to evaluate our future business prospects and make decisions based on those estimates of our future performance. An investor could lose his entire investment.

We have a limited operating history. An investor has no frame of reference to evaluate our future business prospects. This makes it difficult, if not impossible, to evaluate us as an investment. An investor could lose his entire investment if our future business prospects do not result in our ever becoming profitable and sustaining profitability.

We currently rely upon clients under common principal control of our majority shareholder for the majority of our revenues, which means that we could be severally impacted if the current arrangement does not continue and we cannot replace our current clients with other clients.

100% of the revenues of our clients in the first quarter ended March 31, 2015 came from entities which were under common principal ownership with our majority shareholder. This percentage represents an increase of approximately 25% over the prior year's fiscal quarter. Our revenue projections are subject to greater uncertainty than if we had revenue commitments from a number of clients not under common principal ownership. We could be materially impacted if the current arrangement does not continue, and we cannot replace our current clients with other clients. While we have no basis to believe that we will not continue to generate revenue from this arrangement, we cannot assure you that these clients or any of our clients, will continue to purchase our products or services in significant volume, or at all.

If we do not generate adequate revenues to finance our operations, our business may fail.

We were not profitable in the last two quarters. As of March 31, 2015, we had a cash position of $334,855. We anticipate that operating costs will be approximately $380,000 for the fiscal year ending December 31, 2015. These operating costs include payroll and related costs, travel, office lease, contract services and all other costs of operations. We also use contract employees.  However, the operating costs and expected revenue generation are difficult to predict. Since there can be no assurances that revenues will be sufficient to cover operating costs for the foreseeable future, it may be necessary to raise additional funds. Due to our lack of substantial operating history, raising additional funds may be difficult.

Competition in our industry is intense.

Our business plan involves acting as a fee-based marketing and media consultant to client companies. This business is highly competitive. There are numerous similar companies providing such services in the United States of America. Our competitors will have greater financial resources and more expertise in this business. Our ability to develop our business will depend on our ability to successfully market our services in this highly competitive environment. We cannot guarantee that we will be able to do so successfully.

The share control position of WestMountain Blue, LLC will limit the ability of other shareholders to influence corporate actions.

Our largest shareholder, WestMountain Blue, LLC, of which Mr. Klemsz is a 16.8% member, owns 8,505,652 shares and thereby controls approximately 90% of our outstanding shares. Because WestMountain Blue, LLC individually beneficially controls more than a majority of the outstanding shares, other shareholders, individually or as a group, will be limited in their ability to effectively influence the election or removal of our directors, the supervision and management of our business or a change in control of or sale of our company, even if they believed such changes were in the best interest of our shareholders generally.

Our future success depends, in large part, on the continued service of our President and Treasurer

We depend almost entirely on the efforts and continued employment of Mr. Anderson, our President, and Mr. Klemsz, our Treasurer. Mr. Anderson is our primary executive officer, and we will depend on him for nearly all aspects of our operations. We do not have an employment contract with either Mr. Anderson or Mr. Klemsz, and we do not carry key person insurance on the life of either gentleman. The loss of the services of either Mr. Anderson or Mr. Klemsz through incapacity or otherwise, would have a material adverse effect on our business. It would be very difficult to find and retain qualified personnel such as either Mr. Anderson or Mr. Klemsz.

- 16 -

Our success also depends upon our ability to develop relationships with our clients. If we cannot develop sufficient relationships, we may never become profitable.  An investor could lose his entire investment.

We now have one line of business. We operate as a fee-based marketing and media consultant to client companies, which include both public and private entities.  Our success now depends, in large part, on our ability to develop relationships with potential consulting services clients. We have no long-term contracts or other contractual assurances of consulting services. We may never develop sufficient consulting services clients, which would negatively impact our proposed operations. As a result, we may never become profitable or be able to sustain profitability. An investor could lose his entire investment.

Risks Related to an Investment in Our Common Stock

The lack of a broker or dealer to create or maintain a market in our stock could adversely impact the price and liquidity of our securities.

We have no agreement with any broker or dealer to act as a market maker for our securities and there is no assurance that we will be successful in obtaining any market makers. Thus, no broker or dealer will have an incentive to make a market for our stock. The lack of a market maker for our securities could adversely influence the market for and price of our securities, as well as your ability to dispose of, or to obtain accurate information about, and/or quotations as to the price of, our securities.

We have limited experience as a public company.

We have only operated as a public company since 2008. Thus, we have limited experience in complying with the various rules and regulations which are required of a public company. As a result, we may not be able to operate successfully as a public company, even if our operations are successful. We plan to comply with all of the various rules and regulations which are required of a public company. However, if we cannot operate successfully as a public company, your investment may be materially adversely affected. Our inability to operate as a public company could be the basis of your losing your entire investment in us.

We may be required to register under the Investment Company Act of 1940, or the Investment Advisors Act, which could increase the regulatory burden on us and could negatively affect the price and trading of our securities.

Because our business involves the identification, acquisition and development of investments, we may be required to register as an investment company under the Investment Company Act of 1940 or the Investment Advisors Act and analogous state law. While we believe that we are currently either not an investment company or an investment advisor or are exempt from registration as an investment company under the Investment Company Act of 1940 or the Investment Advisors Act and analogous state law, either the SEC or state regulators, or both, may disagree and could require registration either immediately or at some point in the future. As a result, there could be an increased regulatory burden on us which could negatively affect the price and trading of our securities.

Our stock has a limited public trading market on the OTC Bulletin Board and there is no guarantee an active trading market will ever develop for our securities.

There has been, and continues to be, a limited public market for our common stock. We trade under the symbol WASM. An active trading market for our shares has not, and may never develop or be sustained. If you purchase shares of common stock, you may not be able to resell those shares at or above the initial price you paid. The market price of our common stock may fluctuate significantly in response to numerous factors, some of which are beyond our control, including the following:

· actual or anticipated fluctuations in our operating results;

· changes in financial estimates by securities analysts or our failure to perform in line with such estimates;

· changes in market valuations of other companies, particularly those that market services such as ours;

· announcements by us or our competitors of significant innovations,  acquisitions, strategic partnerships, joint ventures or capital commitments;

· introduction of product enhancements that reduce the need for the products our projects may develop;

· departures of key personnel.

- 17 -

Of our total outstanding shares as of March 31, 2015, a total of 8,325,000, or approximately 91.9%, will be restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well.

As restrictions on resale end, the market price of our stock could drop significantly if the holders of restricted shares sell them or are perceived by the market as intending to sell them.

Applicable SEC rules governing the trading of "Penny Stocks" limit the liquidity of our common stock, which may affect the trading price of our common stock.

Our common stock currently trades well below $5.00 per share. As a result, our common stock is considered a "penny stock" and is subject to SEC rules and regulations that impose limitations upon the manner in which our shares can be publicly traded.  These regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock and the associated risks.  Under these regulations, certain brokers who recommend such securities to persons other than established customers or certain accredited investors must make a special written suitability determination for the purchaser and receive the written purchaser's agreement to a transaction prior to purchase.  These regulations have the effect of limiting the trading activity of our common stock and reducing the liquidity of an investment in our common stock.

The over-the-counter market for stock such as ours is subject to extreme price and volume fluctuations.

The securities of companies such as ours have historically experienced extreme price and volume fluctuations during certain periods. These broad market fluctuations and other factors, such as new product developments and trends in the our industry and in the investment markets generally, as well as economic conditions and quarterly variations in our operational results, may have a negative effect on the market price of our common stock.

Buying low-priced penny stocks is very risky and speculative.

Our shares are defined as a penny stock under the Securities and Exchange Act of 1934, and rules of the Commission. The Exchange Act and such penny stock rules generally impose additional sales practice and disclosure requirements on broker-dealers who sell our securities to persons other than certain accredited investors who are, generally, institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000, or $300,000 jointly with spouse, or in transactions not recommended by the broker-dealer. For transactions covered by the penny stock rules, a broker-dealer must make a suitability determination for each purchaser and receive the purchaser's written agreement prior to the sale. In addition, the broker-dealer must make certain mandated disclosures in penny stock transactions, including the actual sale or purchase price and actual bid and offer quotations, the compensation to be received by the broker-dealer and certain associated persons, and deliver certain disclosures required by the Commission. Consequently, the penny stock rules may affect the ability of broker-dealers to make a market in or trade our common stock and may also affect your ability to resell any shares you may purchase in the public markets.

Issuances of our stock could dilute current shareholders and adversely affect the market price of our common stock, if a public trading market develops.

We have the authority to issue up to 50,000,000 shares of common stock, 1,000,000 shares of preferred stock, and to issue options and warrants to purchase shares of our common stock without stockholder approval. Although no financing is planned currently, we may need to raise additional capital to fund operating losses. If we raise funds by issuing equity securities, our existing stockholders may experience substantial dilution. In addition, we could issue large blocks of our common stock to fend off unwanted tender offers or hostile takeovers without further stockholder approval.

The issuance of preferred stock by our board of directors could adversely affect the rights of the holders of our common stock. An issuance of preferred stock could result in a class of outstanding securities that would have preferences with respect to voting rights and dividends and in liquidation over the common stock and could, upon conversion or otherwise, have all of the rights of our common stock. Our board of directors' authority to issue preferred stock could discourage potential takeover attempts or could delay or prevent a change in control through merger, tender offer, proxy contest or otherwise by making these attempts more difficult or costly to achieve.

- 18 -

Colorado law and our Articles of Incorporation protect our directors from certain types of lawsuits, which could make it difficult for us to recover damages from them in the event of a lawsuit.

Colorado law provides that our directors will not be liable to our company or to our stockholders for monetary damages for all but certain types of conduct as directors. Our Articles of Incorporation require us to indemnify our directors and officers against all damages incurred in connection with our business to the fullest extent provided or allowed by law. The exculpation provisions may have the effect of preventing stockholders from recovering damages against our directors caused by their negligence, poor judgment or other circumstances. The indemnification provisions may require our company to use our assets to defend our directors and officers against claims, including claims arising out of their negligence, poor judgment, or other circumstances.

We do not expect to pay dividends on common stock.

We have not paid any cash dividends with respect to our common stock, and it is unlikely that we will pay any dividends on our common stock in the foreseeable future. Earnings, if any, that we may realize will be retained in the business for further development and expansion.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

ITEM 5.  OTHER INFORMATION 

None

- 19 -

ITEM 6.  EXHIBITS

ITEM 6.  EXHIBITS

Exhibit Number	Description
3.1*	Articles of Incorporation
3.2*	Bylaws
3.3 ***	Amendment to Articles of Incorporation
10.1**	Service Agreement With Bohemian Companies, LLC
31.1	Certification of CEO/CFO pursuant to Sec. 302
32.1	Certification of CEO/CFO pursuant to Sec. 906

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document*
101.INS	XBRL Instance Document
101SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

* Previously filed with Form SB-2 Registration Statement, January 2, 2008

** Previously filed with Form 10-KSB Registration Statement, February 29, 2008

*** Previously filed under cover of Form 8K, February 27, 2014.

Reports on Form 8-K

No reports were filed under cover of Form 8-K for the fiscal quarter ended March 31, 2015.

- 20 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized May 15, 2015.

WEST MOUNTAIN COMPANY a  Colorado corporation
By:	/s/ Brian L. Klemsz
	Brian L. Klemsz, President, Chief Executive Officer, Chief Financial Officer and Director (Principal Executive, Accounting and Financial Officer)

- 21 -

EX-31

 Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

     I, Brian L. Klemsz, certify that:

1.   I have reviewed this quarterly report of WestMountain Company on Form 10-Q;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4.   The small business issuer's other certifying officer and I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))  for the small business issuer and have;

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure the material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over   financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and  presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation.

Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or person performing the equivalent functions);

     (a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process summarize and report financial information; and

     (b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal controls over financial reporting.

Date:  May 15, 2015
	/s/ Brian L. Klemsz
	Brian L. Klemsz Chief Executive Officer
	Chief Financial Officer

EX-32

                                                                    Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT 0F 2002

In connection with the Quarterly Report of WestMountain Company (the Company") on Form 10-Q for the period ended herein as filed with the Securities and Exchange Commission (the "Report"), I. Brian L. Klemsz, Chief Executive and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fully presents, in all material respects, the financial condition and results of operations or the Company.

	WEST MOUNTAIN COMPANY
Dated: May 15, 2015
	By:	/s/ Brian L. Klemsz
		Brian L. Klemsz Chief Executive Officer Chief Financial Officer

XML

Related Parties

3 Months Ended

Mar. 31, 2015

Related Party Transactions [Abstract]

Related Parties

(4) Related Parties

Bohemian Companies, LLC and BOCO Investments, LLC are two companies under common control.  Mr. Klemsz, our President, has been the Chief Investment Officer of BOCO Investments, LLC since March 2007.  Since there is common control between the two companies and a relationship with our Company President, we are considering all transactions with Bohemian Companies, LLC and BOCO Investments, LLC, related party transactions.

On January 1, 2008, we entered into a Service Agreement with Bohemian Companies, LLC to provide us with certain defined services. These services include financial, bookkeeping, accounting, legal and tax matters, as well as cash management, custody of assets, preparation of financial documents, including tax returns and checks, and coordination of professional service providers as may be necessary to carry out the matters covered by the Service Agreement.  We compensated Bohemian Companies, LLC by reimbursing this entity for the allocable portion of the direct and indirect costs of each employee of Bohemian Companies, LLC that performs services on our behalf. We received invoices monthly from Bohemian Companies, LLC. This Service Agreement was terminated by mutual agreement of the parties on March 31, 2014.  Total expenses incurred with Bohemian Companies were $3,000 for the three months ending March 31, 2014 and 2013. As of March 31, 2014 the Company had no balance due to Bohemian Companies, LLC.

For the three months ended March 31, 2014 and 2013, the Company recorded management fee revenues of $-0- and $18,678, respectively, for asset management services performed on behalf of WestMountain Prime, LLC, a related party. The Company and WestMountain Prime, LLC are under common principal ownership.  The asset management services contract between WestMountain Prime, LLC and the Company was terminated as of September 30, 2013.

Historically, the Company earned management fees based on the size of the funds managed, and incentive income based on the performance of the funds. With the termination of the asset management services contract between the Company and WestMountain Prime, LLC, the Company no longer provides asset management services to any clients. Further, the Company has elected not to seek any new asset management services clients in the future but to concentrate solely on providing fee-based consulting services for marketing and media clients.

For the three months ended March 31, 2014 and 2013, the Company recorded aggregate advisory/consulting revenue of $50,600 and $60,750, respectively. Of the $50,600 recorded in 2014, $38,000 is related party revenue for services performed on behalf of Nexcore Group LP and Bohemian Asset Management, Inc.  The Company, Nexcore and Bohemian are under common principal ownership. Of the $60,750 recorded in 2013, $30,750 is related party revenue for services performed on behalf of Nexcore Group LP and WestMountain Gold Inc. The Company, Nexcore and WestMountain Gold, Inc. are under common principal ownership.

On October 10, 2013, the Company signed a Marketing/Media Consulting Agreement that was effective October 1, 2013 with Bohemian Asset Management, Inc., a related party due to common ownership. This agreement has an original expiration date of December 31, 2014. We will be paid $20,000 per quarter for general marketing and consulting services, due and payable in advance on the first of each quarter.

As of March 31, 2014 and December 31, 2013, the Company had $16,450 and $394,800, respectively, of accounts receivable from related parties. The amount due in 2013 represents distribution income due from Nexcore Real Estate LLC. The receivable was collected in January 2014.

On September 29, 2010 CapTerra Financial Group, Inc. merged with Nexcore Group LP (“Nexcore”). The Company provided advisory services related to the transaction and for those services received 1,645,000 warrants. In December 2010, these warrants were exercised for common stock of Nexcore Group LP. As of March 31, 2014 and December 31, 2013, no active market existed for these securities and so the Company kept the value of this investment on the books at the aggregate exercise price of $1,645.  The equity securities are restrictive securities.

On January 25, 2013, Nexcore Real Estate, LLC declared $0.01 per share cash dividend payable on February 18, 2013 to holders of NexCore common stock of record on February 4, 2013. As of that date, the Company owned 1,645,000 shares of common stock. In the first quarter 2013, we received a cash dividend of $16,450 that was recorded as dividend on nonmarketable securities.

On January 3, 2014, NexCore Healthcare Capital Corp. declared a $0.10 per share cash dividend to holders of NexCore common stock of record on January 16, 2014. As of that date, the Company owned 1,645,000 shares of common stock and received a cash dividend of $164,500.

As of March 31, 2014 and December 31, 2013, the following investments in marketable and nonmarketable securities were held in related parties due to common principal ownership.

	March 31, 2014			December 31, 2013
			Market/Cost			Market/Cost
Company Name	Shares	Units	Value	Shares	Units	Value
Marketable Securities:
Hangover Joe's Holding Corporation (formerly
Accredited Members Holding Corporation)	928,463	-	$       26,276	928,463	-	$      16,061
WestMountain Gold, Inc. (formerly        WestMountain Index Advisor, Inc.)	918,000	-	780,300	866,000	-	640,840
Total Shares or Units	1,846,463	-	$     806,576	1,794,463	-	$    656,901
Nonmarketable Securities:
Nexcore Real Estate LLC (Class B Units)	-	1,645,000	$                -	-	1,645,000	$                -
Nexcore Healthcare Capital Corp	1,645,000	-	1,645	1,645,000	-	1,645
Totals Shares or Units	1,645,000	1,645,000	$        1,645	1,645,000	1,645,000	$        1,645

XML

Stockholders Equity

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders Equity

(3) Stockholders Equity

Common Stock

There were 9,517,402 shares of common stock outstanding as of March 31, 2014 and December 31, 2013. 

No common shares were issued or cancelled during the three months ended March 31, 2014.

Stock options

On August 15, 2011, the Company approved the employee compensation plan and granted a total of 200,000 common stock options, to our employees. As stated in the compensation plan, these options have a four year term. Fifty percent of the options became vested and exercisable immediately, 25% on the first anniversary date of August 15, 2012, and 25% on the second anniversary date of August 15, 2013. The options have an exercise price of $0.27 per share, which was the fair value of the stock on the day of the grant. The fair value of the options was determined to be $41,038 using the Black Scholes option pricing model.

The significant assumptions in the model included a risk free rate of 0.99%, a volatility input of 99.96% and using the simplified method, the expected term used in the calculation is 2.375 years. As of March 31, 2014, the full fair value of $41,038 has been expensed.

The following table presents the activity for common stock options during the three months ended March 31, 2014:

			Weighted
			Average
		Options	Exercise Price
Outstanding - December 31, 2013		200,000	$                  0.27
	Granted	-	-
	Forfeited/canceled	-	-
	Exercised	-	-
Outstanding - March 31, 2014		200,000	$                  0.27

The weighted average remaining life of these 200,000 options as of March 31, 2014 and December 31, 2013 was 1.4 and 1.6 years respectively.

The following table presents the composition of options outstanding and exercisable as of March 31, 2014 and December 31, 2013. The exercisable options have an intrinsic value of $96,000 and $12,000 as of March 31, 2014 and December 31, 2013, respectively.

As of March 31, 2014:
		Options Outstanding		Options Exercisable
	Range of Exercise Prices	Number	Life	Number	Price
	0.27	200,000	1.4	200,000	0.27
As of December 31, 2013:
		Options Outstanding		Options Exercisable
	Range of Exercise Prices	Number	Life	Number	Price
	0.27	200,000	1.6	200,000	0.27

XML

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$ 334,855	$ 445,411
Investments in marketable securities	803,151	1,006,230
Accounts receivable, related parties	18,000	41,125
Accounts receivable	27,900	12,300
Income tax receivable	5,945
Note receivable, related	52,823	25,937
Prepaid expenses	4,697	9,807
Deferred tax assets, net	139,062
Total current assets	1,386,433	1,540,810
Property and equipment, net of accumulated depreciation of $9,473 and $9,473, respectively	5,659	6,173
Investments in nonmarketable securities, at cost	31,645	31,645
Total assets	1,423,737	1,578,628
Current Liabilities:
Accounts payable and accrued liabilities	32,020	37,293
Deferred tax liability	171,351	107,958
Income tax payable		68,662
Total current liabilities	203,371	213,913
Total liabilities	203,371	213,913
Shareholders' Equity:
Preferred stock, $0.10 par value; 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value; 50,000,000 shares authorized, 9,517,402 shares issued and outstanding	9,518	9,518
Additional paid-in-capital	927,355	927,355
Accumulated earnings (deficit)	(7,570)	8,952
Other comprehensive income, net	291,063	418,890
Total shareholders' equity	1,220,366	1,364,715
Total liabilities and shareholders' equity	$ 1,423,737	$ 1,578,628

XML

Nature of Organization and Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Organization and Summary of Significant Accounting Policies

(1) Nature of Organization and Summary of Significant Accounting Policies

Nature of Organization and Basis of Presentation

WestMountain Company, formerly known as WestMountain Asset Management, Inc. ,(“we”,” our” or the “Company”) was incorporated in the state of Colorado on October 18, 2007 and on this date approved its business plan and commenced operations. The consolidated financial statements include the financial information of WestMountain Company and its wholly owned subsidiaries, WestMountain Business Consulting, Inc., WestMountain Allocation Analytics, Inc. and WestMountain Valuation Services Inc. All significant intercompany accounts and transactions have been eliminated.

Unaudited Financial Information

The accompanying financial information as of March 31, 2014 and for the three months ended March 31, 2014 and 2013 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at March 31, 2014 and its operating results for the three months ended March 31, 2014 and 2013 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2013. The results of operations for the three months ended March 31, 2014 is not necessarily an indication of operating results to be expected for the year.

Commitments and Contingencies

Based on currently available information, the Company believes that it is remote that future costs related to known contingent liability exposures will exceed current accruals by an amount that would have a material adverse impact on our financial statements. As the Company learns new facts concerning contingencies, the Company reassesses its position both with respect to accrued liabilities and other potential exposures. In the case of all known contingencies, the Company accrues a liability when the loss is probable and the amount is reasonably estimable. The Company does not reduce these liabilities for potential insurance or third-party recoveries.

Fair Value of Financial Instruments

Available-for-sale securities are accounted for on a specific identification basis. As of March 31, 2014 and December 31, 2013 respectively, we held available-for-sale marketable securities with an aggregate fair value of $1,386,155 and $1,380,879 respectively.  As of March 31, 2014, all of our available-for-sale securities were invested in publically traded equity holdings. Available-for-sale securities were classified as current based on the percentage of the equity controlled by the Company as well as our intended use of the assets. The Company recognized unrealized losses, net of tax, in accumulated other comprehensive income (loss) for the three months ended March 31, 2014 and 2013 in the amounts of $3,321 and ($151,273), respectively.

The Company’s assets measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 at March 31, 2014 and December 31, 2013, were as follows:

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2014

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	March 31,
Description	(Level 1)	(Level 2)	(Level 3)	2014
Assets:
Available-for-sale
marketable securities	$           1,386,155	$              -	$              -	$        1,386,155

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2013

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	December 31,
Description	(Level 1)	(Level 2)	(Level 3)	2013
Assets:
Available-for-sale
marketable securities	$              1,380,879	$                -	$                   -	$      1,380,879

XML

Stockholders Equity (Stock Option Activity) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2010
Stock option activity
Outstanding, beginning		200,000	200,000	200,000	200,000
Outstanding, ending			200,000	200,000	200,000
Weighted average exercise price, beginning			$ 0.27	$ 0.27	$ 0.27
Weighted average exercise price, ending			$ 0.27	$ 0.27	$ 0.27
Weighted average remaining life	1 year 3 months 2 days	1 year 7 months 6 days

XML

Investments

3 Months Ended

Mar. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Investments

(2)    Investments

Investments in Available for Sale Marketable Securities

The Company’s investments in available for sale marketable securities as of March 31, 2014 and December 31, 2013 are summarized below.

					As of March 31, 2014
									Accumulated
					Share		Market/Cost		Unrealized
Company Name	Shares		Cost		Price		Value		Gain/(Loss)
Omni Bio Pharmaceutical, Inc.		1,707,107	$	193,634	$	0.282	$	481,060	$	287,427
Hangover Joe's Holding Corporation (formerly     Accredited Members Holding Corporation)		928,463		106,641		0.028		26,276		(80,367	)
Silver Verde May Mining Co., Inc		246,294		46,488		0.400		98,518		52,029
WestMountain Gold, Inc. (formerly WestMountain     Index Advisor, Inc.)		918,000		918		0.850		780,300		779,434
Totals		3,799,864	$	347,681			$	1,386,155	$	1,038,523

					As of December 31, 2013
									Accumulated
					Share		Market/Cost		Unrealized
Company Name	Shares		Cost		Price		Value		Gain/(Loss)
Omni Bio Pharmaceutical, Inc.		1,707,107	$	193,634	$	0.3837	$	655,016	$	461,382
Hangover Joe's Holding Corporation (formerly     Accredited Members Holding Corporation)		928,463		106,641		0.0173		16,061		(90,580	)
Silver Verde May Mining Co., Inc.		246,294		46,488		0.2800		68,962		22,474
WestMountain Gold, Inc. (formerly WestMountain     Index Advisor, Inc.)		866,000		866		0.7400		640,840		639,974
Totals		3,747,864	$	347,629			$	1,380,879	$	1,033,250

Investments in Nonmarketable Securities

The Company’s investments in nonmarketable securities accounted for under the cost method as of March 31, 2014 and December 31, 2013 are summarized below.

Company Name	Shares		Units		Cost
Nexcore Healthcare Capital Corp.		1,645,000		-	$	1,645
Nexcore Real Estate LLC (Class B Units)		-		1,645,000		-
SRKP 16, Inc.		200,000		-		30,000
Totals		1,845,000		1,645,000	$	31,645

As of March 31, 2014 and December 31, 2013, the Company recorded $16,450 and $394,800, respectively, as accounts receivable related party on its balance sheet.  In 2013, one of the Company’s investments declared a distribution of $394,800. We recorded the distribution as related party accounts receivable. The receivable was collected in January 2014.

On January 25, 2013, NexCore Real Estate, LLC declared $0.01 per share cash dividend payable on February 18, 2013 to holders of NexCore common stock of record on February 4, 2013. As of that date, the Company owned 1,645,000 shares of common stock and received a cash dividend of $16,450 in May 2014.

On January 3, 2014, NexCore Healthcare Capital Corp. declared a $0.10 per share cash dividend to holders of NexCore common stock of record on January 16, 2014. As of that date, the Company owned 1,645,000 shares of common stock and received a cash dividend of $164,500.

XML

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Assets
Accumulated depreciation	$ 9,473	$ 9,473
Shareholders' Equity:
Preferred stock, par value per share	$ 0.10	$ 0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	9,517,402	9,517,402
Common stock, shares outstanding	9,517,402	9,517,402

XML

Related Parties (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013	Mar. 31, 2014	Dec. 31, 2013
Related Party Transaction [Line Items]
Management fees, related parties		$ 18,678
Advisory/consulting fees, related parties	38,000	30,750
Advisory/consulting revenue from all sources	50,600	60,750
Accounts receivable, related parties			18,000	41,125
Cash dividend per share	$ 0.10	$ 0.01
Dividend income on nonmarketable securities	180,950
Bohemian Companies Limited Liability Company [Member]
Related Party Transaction [Line Items]
Amount of transaction		3,000	3,000
Accrued liabilities, related parties		1,000	0
Nexcore [Member]
Related Party Transaction [Line Items]
Accounts receivable, related parties			394,800
Shares			1,645,000
Dividend income on nonmarketable securities		$ 16,450
Nexcore Real Estate LLC [Member]
Related Party Transaction [Line Items]
Shares			1,645,000

XML

Document and Entity Information (USD $)	3 Months Ended
	Mar. 31, 2015	May 13, 2015
Document and Entity Information [Abstract]
Document Type	10-Q
Entity Registrant Name	Westmountain Company
Entity Central Index Key	0001421603
Document Period End Date	Mar. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		9,517,402
Entity Public Float		$ 300,878
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes

XML

Related Parties (Schedule of Related Party Investments) (Details) (USD $) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Related Party Transaction [Line Items]
Cost	$ 347,681	$ 347,629
Hangover Joes Holding Corp [Member]
Related Party Transaction [Line Items]
Shares	928,463	928,463
Cost	26,276	16,061
WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.)
Related Party Transaction [Line Items]
Shares	918,000	866,000
Cost	780,300	640,840
Nexcore Real Estate LLC Class B Units [Member]
Related Party Transaction [Line Items]
Shares	1,645,000	1,645,000
Cost	1,645
Nexcore Healthcare Capital Corp [Member]
Related Party Transaction [Line Items]
Shares	1,645,000
Cost	$ 1,645

XML

Consolidated Statements of Operations and Other Comprehensive Loss (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013
Revenue:
Advisory/consulting fees, related parties	$ 38,000	$ 30,750
Advisory/consulting fees	12,600	30,000
Management fees, related parties		18,678
Total revenue	50,600	79,428
Operating expenses:
Selling, general and administrative expenses	100,264	84,042
Total operating expenses	100,264	84,042
Loss from operations	(49,664)	(4,614)
Other income/(expense):
Interest income		1
Dividend income on nonmarketable securities	180,950
Realized loss on available for sale marketable securities		16,450
Total other income/(expense)	180,950	16,451
Net income before income taxes	131,286	11,837
Income tax expense (benefit)	(81)	3,031
Net income	131,367	8,806
Comprehensive income (loss)
Unrealized gain (loss) on investments in marketable equity securities, net of tax	3,321	(151,273)
Comprehensive income (loss)	$ 134,688	$ (142,467)
Basic net income (loss) per share	$ 0.01	$ 0.00
Diluted net income (loss) per share	$ 0.01	$ 0.00
Basic weighted average common shares outstanding	9,517,402	9,517,402
Diluted weighted average common shares outstanding	9,601,985	9,597,574

XML

Nature of Organization and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Financial Assets Measured at Fair Value on a Recurring Basis

The Company’s assets measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 at March 31, 2014 and December 31, 2013, were as follows:

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2014

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	March 31,
Description	(Level 1)	(Level 2)	(Level 3)	2014
Assets:
Available-for-sale
marketable securities	$           1,386,155	$              -	$              -	$        1,386,155

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2013

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	December 31,
Description	(Level 1)	(Level 2)	(Level 3)	2013
Assets:
Available-for-sale
marketable securities	$              1,380,879	$                -	$                   -	$      1,380,879

XML

Nature of Organization and Summary of Significant Accounting Policies (Policy)

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Organization and Basis of Presentation

Nature of Organization and Basis of Presentation

WestMountain Company, formerly known as WestMountain Asset Management, Inc. ,(“we”,” our” or the “Company”) was incorporated in the state of Colorado on October 18, 2007 and on this date approved its business plan and commenced operations. The consolidated financial statements include the financial information of WestMountain Company and its wholly owned subsidiaries, WestMountain Business Consulting, Inc., WestMountain Allocation Analytics, Inc. and WestMountain Valuation Services Inc. All significant intercompany accounts and transactions have been eliminated.

Unaudited Financial Information

Unaudited Financial Information

The accompanying financial information as of March 31, 2014 and for the three months ended March 31, 2014 and 2013 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at March 31, 2014 and its operating results for the three months ended March 31, 2014 and 2013 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2013. The results of operations for the three months ended March 31, 2014 is not necessarily an indication of operating results to be expected for the year.

Commitments and Contingencies

Commitments and Contingencies

Based on currently available information, the Company believes that it is remote that future costs related to known contingent liability exposures will exceed current accruals by an amount that would have a material adverse impact on our financial statements. As the Company learns new facts concerning contingencies, the Company reassesses its position both with respect to accrued liabilities and other potential exposures. In the case of all known contingencies, the Company accrues a liability when the loss is probable and the amount is reasonably estimable. The Company does not reduce these liabilities for potential insurance or third-party recoveries.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Available-for-sale securities are accounted for on a specific identification basis. As of March 31, 2014 and December 31, 2013 respectively, we held available-for-sale marketable securities with an aggregate fair value of $1,386,155 and $1,380,879 respectively.  As of March 31, 2014, all of our available-for-sale securities were invested in publically traded equity holdings. Available-for-sale securities were classified as current based on the percentage of the equity controlled by the Company as well as our intended use of the assets. The Company recognized unrealized losses, net of tax, in accumulated other comprehensive income (loss) for the three months ended March 31, 2014 and 2013 in the amounts of ($3,321) and ($151,273), respectively.

The Company’s assets measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 at March 31, 2014 and December 31, 2013, were as follows:

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2014

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	March 31,
Description	(Level 1)	(Level 2)	(Level 3)	2014
Assets:
Available-for-sale
marketable securities	$           1,386,155	$              -	$              -	$        1,386,155

Assets and Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2013

	Quoted Prices in	Significant
	Active Markets for	Other	Significant
	Identical Assets and	Observable	Unobservable	Balance as of
	Liabilities	Inputs	Inputs	December 31,
Description	(Level 1)	(Level 2)	(Level 3)	2013
Assets:
Available-for-sale
marketable securities	$              1,380,879	$                -	$                   -	$      1,380,879

XML

Stockholders Equity (Exercisable and Outstanding Options by Exercise Price Range) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013	Mar. 31, 2014	Dec. 31, 2013
Options by exercise price range
Options exercisable, intrinsic value			$ 96,000	$ 12,000
Minimum exercise price	$ 0.27	$ 0.27
Options outstanding			200,000	200,000
Options exercisable outstanding			200,000	200,000
Weighted average remaining life	1 year 3 months 2 days	1 year 7 months 6 days

XML

Investments (Cost Method Nonmarketable Investments) (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
SKRP 16 Inc [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	200,000	200,000
Cost	$ 30,000	$ 30,000
Nexcore Real Estate LLC [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	1,645,000	1,645,000
Nexcore Healthcare Capital [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	1,645,000	1,645,000
Cost	$ 1,645	$ 1,645

XML

Stockholders Equity (Tables)

3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Schedule of Common Stock Option Activity

The following table presents the activity for common stock options during the three months ended March 31, 2014:

			Weighted
			Average
		Options	Exercise Price
Outstanding - December 31, 2013		200,000	$                  0.27
	Granted	-	-
	Forfeited/canceled	-	-
	Exercised	-	-
Outstanding - March 31, 2014		200,000	$                  0.27

Schedule of Options Outstanding and Exercisable, by Exercise Price Range

The following table presents the composition of options outstanding and exercisable as of March 31, 2014 and December 31, 2013. The exercisable options have an intrinsic value of $96,000 and $12,000 as of March 31, 2014 and December 31, 2013, respectively.

As of March 31, 2014:
		Options Outstanding		Options Exercisable
	Range of Exercise Prices	Number	Life	Number	Price
	0.27	200,000	1.4	200,000	0.27
As of December 31, 2013:
		Options Outstanding		Options Exercisable
	Range of Exercise Prices	Number	Life	Number	Price
	0.27	200,000	1.6	200,000	0.27

XML

Investments (Tables)

3 Months Ended

Mar. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Schedule of Investments in Available for Sale Marketable Securities

Investments in Available for Sale Marketable Securities

The Company’s investments in available for sale marketable securities as of March 31, 2014 and December 31, 2013 are summarized below.

					As of March 31, 2014
									Accumulated
					Share		Market/Cost		Unrealized
Company Name	Shares		Cost		Price		Value		Gain/(Loss)
Omni Bio Pharmaceutical, Inc.		1,707,107	$	193,634	$	0.282	$	481,060	$	287,427
Hangover Joe's Holding Corporation (formerly Accredited Members Holding Corporation)		928,463		106,641		0.028		26,276		(80,367	)
Silver Verde May Mining Co., Inc		246,294		46,488		0.400		98,518		52,029
WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.)		918,000		918		0.850		780,300		779,434
Totals		3,799,864	$	347,681			$	1,386,155	$	1,038,523

					As of December 31, 2013
									Accumulated
					Share		Market/Cost		Unrealized
Company Name	Shares		Cost		Price		Value		Gain/(Loss)
Omni Bio Pharmaceutical, Inc.		1,707,107	$	193,634	$	0.3837	$	655,016	$	461,382
Hangover Joe's Holding Corporation (formerly Accredited Members Holding Corporation)		928,463		106,641		0.0173		16,061		(90,580	)
Silver Verde May Mining Co., Inc.		246,294		46,488		0.2800		68,962		22,474
WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.)		866,000		866		0.7400		640,840		639,974
Totals		3,747,864	$	347,629			$	1,380,879	$	1,033,250

Investments in Nonmarketable Securities

Company Name	Shares		Units		Cost
Nexcore Healthcare Capital Corp.		1,645,000		-	$	1,645
Nexcore Real Estate LLC (Class B Units)		-		1,645,000		-
SRKP 16, Inc.		200,000		-		30,000
Totals		1,845,000		1,645,000	$	31,645

XML

Related Parties (Tables)

3 Months Ended

Mar. 31, 2015

Related Parties Tables

Securities held in related parties due to common principal ownership

	March 31, 2014			December 31, 2013
			Market/Cost			Market/Cost
Company Name	Shares	Units	Value	Shares	Units	Value
Marketable Securities:
Hangover Joe's Holding Corporation (formerly
Accredited Members Holding Corporation)	928,463	-	$       26,276	928,463	-	$      16,061
WestMountain Gold, Inc. (formerly        WestMountain Index Advisor, Inc.)	918,000	-	780,300	866,000	-	640,840
Total Shares or Units	1,846,463	-	$     806,576	1,794,463	-	$    656,901
Nonmarketable Securities:
Nexcore Real Estate LLC (Class B Units)	-	1,645,000	$                -	-	1,645,000	$                -
Nexcore Healthcare Capital Corp	1,645,000	-	1,645	1,645,000	-	1,645
Totals Shares or Units	1,645,000	1,645,000	$        1,645	1,645,000	1,645,000	$        1,645

XML

Nature of Organization and Summary of Significant Accounting Policies (Fair Value of Financial Instruments) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013	Mar. 31, 2014	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Aggregate fair value of available-for-sale securities			$ 1,386,155	$ 1,380,879
Unrealized loss on investments in marketable equity securities, net of tax	$ 3,321	$ (151,273)

XML

Stockholders Equity (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2011	Aug. 15, 2011	Dec. 31, 2010
Stockholders' Equity Note [Abstract]
Outstanding shares			9,517,402	9,517,402
Shares authorized under stock option plan				200,000		200,000
Terms of options per compensation plan agreement (in years)	4 years
Percentage of options that vest and are exercisable immediately						50.00%
Percentage of options that vest on the first anniversary date of August 15, 2011						25.00%
Percentage of options that vest on the second anniversary date of August 15, 2012						25.00%
Exercise price				$ 0.27	$ 0.27		$ 0.27
Fair value	$ 41,038
Risk free interest rate	99.00%
Volatility rate	99.00%
Expected life in years	2 years 1 month 6 days
Share-based compensation expense recognized during the period	$ 41,038	$ 114,110

XML

Condensed Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 131,367	$ 8,806
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	602	702
Stock based compensation expense		2,530
Income tax (benefit) expense	(81)	3,031
Changes in operating assets and operating liabilities:
Prepaid expenses and other current assets	(1,675)	(309)
Accounts receivable	4,800	(4,000)
Accounts receivable, related parties	378,350	6,550
Income tax receivable	(8,441)
Accounts payable and accrued liabilities	(78,983)	11,404
Accounts payable, related parties		(1,000)
Deferred revenue		(12,000)
Net cash provided by operating activities	425,939	15,732
Cash flows from investing activities:
Purchases of investments	(52)
Net cash used in investing activities	(52)
Net change in cash and cash equivalents	425,887	15,732
Cash and cash equivalents, beginning of period		50,257
Cash and cash equivalents, end of period		65,989
Supplemental disclosure of cash flow information:
Cash paid during the period for Income tax	42,000
Cash paid during the period for Interest
Non cash investing and financing activities:
Unrealized (income) loss on investments in marketable securities	(3,321)	151,273
Conversion of notes receivable to marketable securities

XML

Subsequent Event

3 Months Ended

Mar. 31, 2015

Subsequent Events [Abstract]

Subsequent Event

(5) Subsequent Event

              Effective April 1, 2014, we relocated our principal executive office to 181 W. Boardwalk, Suite 202, Fort Collins, Colorado 80525. We signed a two year lease for a total of 565 square feet of office space at a price of $188 per month plus costs associated with yearly common area fees. For the current year, the additional cost will be $61.  Our phone number is 970-223-4499.

XML

Investments (Available for Sale Marketable Securities) (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Cost	$ 347,681	$ 347,629
Market/Cost Value	803,151	1,006,230
Accumulated Unrealized Gain/Loss	1,038,523	1,033,250
Omni Bio Pharmaceutical, Inc. [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares	1,707,107	1,707,107
Cost	193,634	193,634
Share Price	$ 0.282	$ 0.3837
Market/Cost Value	481,060	655,016
Accumulated Unrealized Gain/Loss	287,427	461,382
Hangover Joe's Holding Corporation [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares	928,463	928,463
Cost	106,641	106,641
Share Price	$ 0.028	$ 0.0173
Market/Cost Value	26,276	16,061
Accumulated Unrealized Gain/Loss	(80,367)	(90,580)
Silver Verde May Mining Co., Inc [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares	246,294	246,294
Cost	46,488	46,488
Share Price	$ 0.400	$ 0.28
Market/Cost Value	98,518	68,962
Accumulated Unrealized Gain/Loss	52,029	22,474
WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.) [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares	918,000	866,000
Cost	918	866
Share Price	$ 0.850	$ 0.74
Market/Cost Value	780,300	640,840
Accumulated Unrealized Gain/Loss	$ 779,434	$ 639,974